CHI3L1 and Alzheimer disease: Thus, based on these aspects, we aim to analyse the YKL-40 CSF levels power to predict neurodegeneration (specific to MCI, AD, or MCI-AD), and to evaluate its potential for differential diagnosis and therapeutical response.